Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects

NCT05933824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV (Human Immunodeficiency Virus)

Interventions

DRUG: LP-98 injection

Sponsor

Shanxi Kangbao Biological Product Co., Ltd.

Collaborators

[object Object]